心理学の研究とレビュー

Newer Drugs in the Management of Copd

Phani Bhavana Cherukuri

Chronic obstructive pulmonary disease is widespread throughout the world, especially in developing countries. It is a disorder of the lung characterized by airflow obstruction, inflammation and tissue remodeling. Management of patients with COPD is complex and so treatment strategies are an important issue. The pharmacological treatment of chronic obstructive pulmonary disease (COPD) is offered in a variety of new single, double and triple therapies. These include short-acting beta-2 agonists, long-acting beta-2 agonists, short-acting muscarinic antagonists, long-acting muscarinic antagonists, or inhaled corticosteroids.